CD8A and chronic myelogenous leukemia, BCR-ABL1 positive: Compared with the majority of solid tumors, CML cells have a low mutational burden resulting in the generation of only a limited number of neo-antigens that may be detected by specific CD8+ cytotoxic T cells (CTLs; ref. 13).